FERRONI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 4.610
AS - Asia 3.310
EU - Europa 429
Continente sconosciuto - Info sul continente non disponibili 134
SA - Sud America 132
AF - Africa 34
OC - Oceania 10
Totale 8.659
Nazione #
US - Stati Uniti d'America 3.896
TR - Turchia 1.770
CN - Cina 745
CA - Canada 699
SG - Singapore 631
IT - Italia 168
EU - Europa 132
BR - Brasile 115
IN - India 61
IE - Irlanda 51
DE - Germania 39
GB - Regno Unito 29
RU - Federazione Russa 22
FI - Finlandia 20
ES - Italia 16
UA - Ucraina 16
FR - Francia 15
HK - Hong Kong 13
ID - Indonesia 12
MX - Messico 12
ZA - Sudafrica 12
BD - Bangladesh 10
JP - Giappone 10
NL - Olanda 10
PL - Polonia 10
VN - Vietnam 10
SC - Seychelles 9
SE - Svezia 9
SA - Arabia Saudita 8
AU - Australia 7
IR - Iran 7
AR - Argentina 5
CL - Cile 5
DK - Danimarca 5
IQ - Iraq 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
LT - Lituania 4
PH - Filippine 4
LB - Libano 3
MA - Marocco 3
RO - Romania 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
CR - Costa Rica 2
EC - Ecuador 2
EG - Egitto 2
GR - Grecia 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GH - Ghana 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NE - Niger 1
NO - Norvegia 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 8.659
Città #
Kocaeli 1.570
San Mateo 1.183
Toronto 672
Wilmington 331
Houston 301
Santa Clara 247
Lawrence 223
Princeton 223
Singapore 202
Beijing 197
Chandler 168
Ashburn 108
Fairfield 95
Seattle 84
Woodbridge 83
Shanghai 76
Guangzhou 53
Los Angeles 53
Cambridge 41
The Dalles 30
Rome 27
Shenzhen 27
Brooklyn 25
Redwood City 23
Helsinki 20
Columbus 19
Dublin 17
Saint Petersburg 17
Dallas 12
Hong Kong 12
Milan 12
Redmond 12
Wuhan 12
Council Bluffs 11
Jiaxing 10
Nanjing 10
New York 10
Chicago 9
Kyiv 9
Warsaw 9
Wuxi 9
Xi'an 9
Bandung 8
Johannesburg 8
São Paulo 8
London 7
Tokyo 7
Quanzhou 6
San Francisco 6
Zhengzhou 6
Brasília 5
Changsha 5
Hefei 5
Mexico City 5
Montreal 5
Munich 5
Rio de Janeiro 5
Taizhou 5
Wuhu 5
Aarhus 4
Amsterdam 4
Atlanta 4
Bari 4
Chennai 4
Hyderabad 4
Nairobi 4
Nantong 4
Pesaro 4
Phoenix 4
Qingdao 4
Rui'an 4
Stockholm 4
Tehran 4
Xuzhou 4
Zibo 4
Ankara 3
Austin 3
Barcelona 3
Boardman 3
Borgosesia 3
Buffalo 3
Charlotte 3
Dongyang 3
Hanoi 3
Ho Chi Minh City 3
Jinhua 3
Joinville 3
Las Pinas 3
New Jersey 3
Ningbo 3
Pataskala 3
Pune 3
Riyadh 3
Xiamen 3
Anaheim 2
Andover 2
Auckland 2
Baltimore 2
Basra 2
Beirut 2
Totale 6.495
Nome #
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 110
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 103
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 73
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study 67
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 66
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 60
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 55
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 55
Soluble P-selectin: A marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease 54
Activation of blood coagulation in breast cancer - relationship to clinical outcome 54
In vitro interactions between blood platelets and human colorectal tumor cells 53
Role of interleukin-6 in the diagnosis of acute aortic dissection 52
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 52
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 52
“Personal and sensitive data in the e-health-IoT universe” 52
Higher oxidative stress in hepatitis C than hepatitis B virus cirrhotic patients 51
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 51
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 50
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 50
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 50
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 50
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group 50
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody 50
Ideal Body Mass Index (BMI) difference between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 50
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 49
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 49
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 49
Enhanced interleukin-1 beta in hypercholesterolemia - Effects of simvastatin and low-dose aspirin 49
Endothelial dysfunction and oxidative stress in arterial hypertension 48
Changes of the lag phase of collagen-induced platelet aggregation in long-term aspirin therapy 48
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 48
Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation 48
Chronic obstructive pulmonary disease. A possible correlation between platelet aggregation tests and respiratory indexes. ECOB Group 48
Is CEA serum measurement useful in monitoring breast cancer patients? 47
Serum Metalloproteinase-9 Levels in Patients with Coronary Heart Disease A Novel Marker of Inflammation 47
Non-Communicable Diseases: Gender Differences in Therapy 47
EVALUATION OF THE CLINICAL UTILITY OF PLATELET-AGGREGATION STUDIES IN THE LONG-TERM FOLLOW-UP OF PATIENTS WITH ATHEROSCLEROTIC VASCULAR-DISEASE 47
Evaluation of the clinical impact of serum tumor markers in gastric cancer. A prospective longitudinal study 47
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 47
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 47
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 47
Platelet activation, inflammatory mediators and hypercholesterolemia 46
CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients 46
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 46
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 46
Machine learning approach to predict medication overuse in migraine patients 46
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 45
EFFECTS ON PLATELET-FUNCTION BY HUMAN INTERFERON-BETA IN CARCINOMA PATIENTS 45
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 45
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 45
Platelet activation in type 2 diabetes mellitus 45
Ganglioside content of human platelets - Differences in resting and activated platelets 45
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 45
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 45
Platelet activation and low-grade inflammation in hypertensives with or without microalbuminuria 45
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 45
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease 45
Relation of Cytokine Production and Helicobacter Pylori Infection to Coronary Heart Disease 44
Evaluation of the Clinical Impact of Serum Tumor Markers in Colorectal Cancer A Prospective Longitudinal Study 44
Biomarkers of platelet activation in acute coronary syndromes 44
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 44
HEMOSTATIC BALANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 44
Low-density lipoprotein-lowering medication and platelet function 44
Aging: an important risk factor in chemotherapy-associated vascular diseases 44
Interleukin-6 levels in thyroid cancer and nodular goitre 43
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 43
Anoxia-Reoxygenation Enhances Platelet Thromboxane A2 Production via Reactive Oxygen Species-Generated NOX2 Effect in Patients Undergoing Elective Percutaneous Coronary Intervention 43
Identification of blood leukotrienes in classical migraine 43
Combined evaluation of CA 242 and CEA tumor markers in the management of colorectal cancer 43
Breast Cancer Prognosis Using a Machine Learning Approach 43
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 42
VEGF and VTE Risk in Cancer Patients-Letter 42
Serum Concentration of Soluble Adhesion Molecules and Cytokines in Patients with Colorectal Cancer 42
Increased plasminogen activator inhibitor-1 levels in android obesity: correlation with oxidative stress 42
Effects of storage on in vitro platelet responses: Comparison of ACD and Na citrate anticoagulated samples 42
Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction 42
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease 42
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 42
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 41
Determinants of platelet activation in pulmonary arterial hypertension 41
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 41
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 41
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 41
Prognostic value of vascular endothelial growth factor (VEGF) tumor tissue content in colorectal cancer - association with carcinoembryonic antigen (CEA) 40
Soluble P-selection and pro-inflammatory cytokine in patients with hypercholesterolemia 40
The value of soluble selectin levels in the management of lung cancer patients 40
Predictive criteria for the choice of serum tumor marker(s) to improve the detection of recurrent gastric cancer 40
Lipid peroxidation as a determinant of platelet activation in hypertensives with microalbuminuria 40
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 40
Lipoprotein(a) serum levels in patients with chronic obstructive pulmonary disease 40
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 40
CD40/CD40L system and vascular disease 40
Impact of chemotherapy on venous thromboembolism. Comment to: Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study, by Dickmann B, et al 40
Arterial hypertension and cardiovascular risk: need for a combined strategy of intervention 40
THERAPEUTIC POTENTIAL OF ANTIPLATELET AGENTS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 40
Prognostic value of soluble P-selectin levels in colorectal cancer 40
Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress 39
Effects of normothermic versus hypothermic cardiopulmonary bypass on cytokine production and platelet function 39
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer 39
Possible correlations between platelet activation and inflammatory response during cardiopulmonary bypass 39
Totale 4.730
Categoria #
all - tutte 97.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.376 104 152 26 3 58 110 62 37 67 50 1.575 132
2021/20222.230 8 673 675 4 3 3 284 238 27 279 4 32
2022/2023841 490 18 18 54 33 11 2 35 31 65 84 0
2023/2024497 4 0 9 121 26 20 7 25 1 49 1 234
2024/20252.053 88 477 110 90 110 355 147 106 206 14 70 280
2025/2026140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 8.980